Vaccination Strategies Against Hepatitis A in Travelers Older Than 40 Years: An Economic Evaluation

Abstract

The CVP was lower than the prevalence rate found in our international travelers. Therefore, we recommend systematic screening for HAV antibodies before selective vaccination of international travelers aged >40 years traveling to hepatitis A endemic zones.